News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
November 9, 2026
2026

AbCellera Reports Q3 2026 Business Results

Read article
News
November 5, 2026
2026

AbCellera to Present at the UBS Global Biopharma Conference on November 17, 2026

Read article
News
October 22, 2026
2026

AbCellera to Present at Upcoming Investor Conferences in November 2026

Read article
News
October 8, 2026
2026

AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting

Read article
News
October 1, 2026
2026

AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026

Read article
News
September 16, 2026
2026

AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026

Read article
News
September 2, 2026
2026

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

Read article
News
August 12, 2026
2026

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

Read article
News
August 11, 2026
2026

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Read article
News
August 10, 2026
2026

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

Read article